Whole human genome microarray

Agilent Technologies has announced commercialisation of its whole human genome microarray compatible with major 1 x 3" microarray scanners. This microarray benefits scientists researching disease and developing therapeutic interventions in such areas as cancer and cardiovascular disease.

Agilent's 60-mer oligo microarray systems provide high sensitivity, resulting in better detection of low-expressing (or rare) genes. As an open-platform solutions provider, Agilent also enables scientists to easily migrate from lab-made, 1 x 3" microarrays to commercial microarrays with low start-up costs.

Agilent's whole human genome microarray represents approximately 41,000 genes and transcripts, based on the most current genomics information available.

The microarray includes up-to-date content and annotations from the major public sequence databases, including RefSeq, GoldenPath and Ensembl. Additional space is available on each microarray for the inclusion of customer-proprietary genes via Agilent's Custom Microarray Services.

Based on the industry-standard 1 x 3" glass-slide format, Agilent's whole human genome oligo microarray does not require researchers to purchase a new scanner. Researchers can take best advantage of the increased genome content coverage and high sensitivity by using Agilent's high-performance DNA microarray scanner and feature extraction software. Alternatively, laboratories with 1 x 3" microarray scanners can run Agilent's microarrays on their existing equipment and feature extract them using BioDiscovery's ImaGene image analysis software.